Despite the anticancer
potential of natural products (NPs), their
limited bioavailability necessitates laborious derivatization or covalent
conjugation to delivery vehicles. To unleash their potential, we developed
a nanohybrid delivery platform with a noncovalently tunable surface.
Initially, the active compound was encapsulated in a macrocycle, p-sulfonatocalix[4]arene, enabling a 62 000-fold
aqueous solubility amplification as also a 2.9-fold enhancement in
its cytotoxicity with respect to the parent compound in SW-620 colon
cancer cells. A pH stimuli responsive behavior was recorded for this
formulate, where a programmable release of quercetin from the macrocycle
was monitored in an acidic environment. Then, a nanoparticle gold
core was decorated with calixarene hosts to accommodate noncovalently
NPs. The loaded nanocarrier with the NP quercetin dramatically enhanced
the cytotoxicity (>50-fold) of the parent NP in colon cancer and
altered
its cell membrane transport mode. In vivo experiments
in a mouse 4T1 tumor model showed a reduction of tumor volume in mice
treated with quercetin-loaded nanoparticles without apparent toxic
effects. Further analysis of the tumor-derived RNA highlighted that
treatment with quercetin-loaded nanoparticles altered the expression
of 27 genes related to apoptosis